HKSecWiki新股资讯 2022年09月23日
11:06 PM EDT, 09/22/2022 (MT Newswires) -- $JENSCARE-B(09877.HK)$ is targeting to raise up to HK$232.6 million ($29.6 million) from its initial public offering in Hong Kong.
美国东部时间2022年09月22日晚上11：06(MT新闻通讯社)--$JENSCARE-B(09877.HK)$该公司计划通过在香港的首次公开募股(IPO)筹集至多2.326亿港元(合2960万美元)。
The high-tech medical equipment provider launched Friday its IPO of 8,076,400 shares, to be priced in the range of HK$26.70 to HK$28.80 per share, according to a same-day filing.
根据同日提交的一份文件，这家高科技医疗设备提供商上周五启动了8,076,400股IPO，发行价将在每股26.70港元至28.80港元之间。
The company expects to determine the price of the IPO on Sept. 29. The company will disclose the results on Oct. 7, in time for its trading debut on the stock exchange on Oct. 10.
该公司预计将于9月9日确定IPO价格。29.该公司将于10月7日公布业绩，赶在10月10日在证券交易所首次亮相。
Proceeds from the offering will be used for research and development, manufacturing and commercialization of its LuX-Valve and Ken-Valve products. It will also use part of the funding for working capital and general corporate purposes.
此次发行所得资金将用于其Lux-Valve和Ken-Valve产品的研发、制造和商业化。它还将把部分资金用于营运资金和一般企业用途。
The company attracted $LIFETECH SCI(01302.HK)$ as a cornerstone investor.
该公司吸引了$LifeTech SCI(01302.HK)$作为基石投资者。
China International Capital Corp., Citigroup, Huatai Financial Holdings, ABCI Capital, BOCOM International Securities, Futu Securities International, and Tiger Brokers are the joint bookrunners and lead managers of the IPO.
中金公司、花旗集团、华泰证券金控、ABCI Capital、交银国际证券、富途证券国际和老虎经纪公司是此次IPO的联席簿记管理人和牵头经办人。
本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠，亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
Was this helpful?
0 / 0
本文链接： https://www.hksecwiki.com/news/p19807409/
由HKSecWiki香港券商百科整理发布，香港证券开户请访问hksecwiki.com